We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
-0.18%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
–
AUM
$1.88B
AUM Growth
-$312M
Cap. Flow
-$314M
Cap. Flow %
-16.69%
Top 10 Hldgs %
23.69%
Holding
207
New
35
Increased
64
Reduced
46
Closed
62

Top Buys

Rank Stock Value
1
ADM icon
Archer Daniels Midland
ADM
+$35.4M
2
SNX icon
TD Synnex
SNX
+$24M
3
MMM icon
3M
MMM
+$23.6M
4
MLCO icon
Melco Resorts & Entertainment
MLCO
+$17.8M
5
OPLN
Openlane
OPLN
+$16.9M

Top Sells

Rank Stock Value
1
QDEL icon
QuidelOrtho
QDEL
+$37.1M
2
CMCSA icon
Comcast
CMCSA
+$36.9M
3
ILMN icon
Illumina
ILMN
+$32.3M
4
C icon
Citigroup
C
+$29.7M
5
VTRS icon
Viatris
VTRS
+$22.4M

Sector Composition

Rank Sector Weight
1 Technology 20.32%
2 Consumer Discretionary 17.17%
3 Energy 12.32%
4 Healthcare 9.35%
5 Consumer Staples 8.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EVTC icon
126
Evertec
EVTC
$1.77B
$2.41M 0.13%
+60,314
New +$2.38M
NGVT icon
127
Ingevity
NGVT
$2.65B
$2.12M 0.11%
44,447
-2,137
-5% -$96K
EAF icon
128
GrafTech
EAF
$205M
$2.01M 0.11%
145,642
+68,760
+89% +$1.07M
LYEL icon
129
Lyell Immunopharma
LYEL
$351M
$1.94M 0.1%
43,576
+6,255
+17% +$268K
LEXX icon
130
Lexaria Bioscience
LEXX
$9.07M
$1.72M 0.09%
31,551
-17,248
-35% -$659K
SMP icon
131
Standard Motor Products
SMP
$885M
$1.68M 0.09%
50,077
-1,227
-2% -$44.9K
TBI
132
Trueblue
TBI
$323M
$1.56M 0.08%
+124,337
New +$1.61M
TBRG
133
DELISTED
TruBridge
TBRG
$1.37M 0.07%
148,779
+73,253
+97% +$709K
NDLS icon
134
Noodles & Co
NDLS
$96M
$1.34M 0.07%
87,874
-3,503
-4% -$68.4K
XERS icon
135
Xeris Biopharma Holdings
XERS
$1.46B
$1.34M 0.07%
604,512
+35,893
+6% +$92.9K
MEI icon
136
Methode Electronics
MEI
$581M
$1.16M 0.06%
95,499
-2,655
-3% -$50.1K
LASR icon
137
nLIGHT
LASR
$2.94B
$1.16M 0.06%
89,350
+4,973
+6% +$65.2K
SA
138
Seabridge Gold
SA
$3.36B
$1.01M 0.05%
67,093
-5,327
-7% -$62.1K
PETS icon
139
PetMed Express
PETS
$42.1M
$1.01M 0.05%
210,229
-5,571
-3% -$32.4K
NAK
140
Northern Dynasty Minerals
NAK
$953M
$915K 0.05%
2,878,547
-50,308
-2% -$13.9K
ASTL icon
141
Algoma Steel
ASTL
$468M
$703K 0.04%
82,786
-4,216
-5% -$35.6K
DSP icon
142
Viant Technology
DSP
$282M
$561K 0.03%
52,589
-386,782
-88% -$3.37M
CVEO icon
143
Civeo
CVEO
$330M
$549K 0.03%
20,458
-358
-2% -$8.32K
UNFI icon
144
United Natural Foods
UNFI
$2.8B
$213K 0.01%
18,500
-73,735
-80% -$1.07M
CSTE icon
145
Caesarstone
CSTE
$88.2M
$147K 0.01%
36,046
-233,288
-87% -$955K
AAP icon
146
Advance Auto Parts
AAP
$3.36B
– –
-140,008
Closed -$8.54M
AEP icon
147
American Electric Power
AEP
$66.9B
– –
-98,849
Closed -$8.03M
ANIK icon
148
Anika Therapeutics
ANIK
$277M
– –
-210,332
Closed -$4.77M
APP icon
149
Applovin
APP
$113B
– –
-22,669
Closed -$903K
AVNS
150
DELISTED
Avanos Medical
AVNS
– –
-119,605
Closed -$2.68M
4 5
6
7 8

Similar funds

SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
ORCP
One Rock Capital Partners New York $2.19B AUM
ET
Entropy Technologies New York $2.17B AUM 21.46% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
MIAS
Mason Investment Advisory Services Reston, Virginia $2.17B AUM 28.39% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
IIP
Intermede Investment Partners London, United Kingdom $2.16B AUM 18.47% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Invenomic Capital Management's Q1 2024 Portfolio in Review

As of Q1 2024, Invenomic Capital Management held 207 positions worth $1.88B, down 14% from $2.19B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Invenomic Capital Management withdrew a net $314M in Q1 2024, closing 62 positions and reducing 46 holdings. Its most notable exit was QuidelOrtho, an estimated $37.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Energy.

Against the trend, Invenomic Capital Management opened a new position in Archer Daniels Midland worth $37.9M.

  • Invenomic Capital Management's largest Q1 2024 buy was Archer Daniels Midland: 603,681 shares worth $37.9M.
  • Invenomic Capital Management added most to 3M in Q1 2024, an estimated $23.6M increase.
  • Invenomic Capital Management's biggest Q1 2024 reduction was Illumina, cutting an estimated $32.3M.
  • Invenomic Capital Management fully exited QuidelOrtho in Q1 2024, selling an estimated $37.1M.
  • Invenomic Capital Management's ten largest holdings make up 24% of its $1.88B portfolio in Q1 2024.
  • Invenomic Capital Management opened 35 new positions and closed 62 in Q1 2024.
  • Invenomic Capital Management's portfolio value fell 14% quarter-over-quarter to $1.88B.

Based on Invenomic Capital Management's 13F filing for Q1 2024, filed 15 May 2024.